Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

HROW

Harrow (HROW)

Harrow Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:HROW
DateTimeSourceHeadlineSymbolCompany
12:51PMiHub NewswireFeaturedCannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa
04/25/20247:00AMBusiness WireHarrow Will Release First Quarter 2024 Financial Results After Market Close on May 13, 2024NASDAQ:HROWHarrow Inc
04/02/20248:16AMBusiness WireMelt Pharmaceuticals Closes $24 Million Series B Preferred Stock FinancingNASDAQ:HROWHarrow Inc
03/20/20247:15AMIH Market NewsJPMorgan boosts dividends, Chipotle unveils 50:1 stock split, and Latest NewsNASDAQ:HROWHarrow Inc
03/19/20245:45PMBusiness WireHarrow Announces Fourth Quarter and Year-End 2023 Financial ResultsNASDAQ:HROWHarrow Inc
03/19/20247:27AMIH Market NewsUS Index Futures Decline Ahead of Federal Reserve Meeting, Oil Prices RetreatNASDAQ:HROWHarrow Inc
03/06/20246:06AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HROWHarrow Inc
03/05/20247:00AMBusiness WireHarrow Will Release Fourth Quarter and Year-End 2023 Financial Results After Market Close on March 19, 2024NASDAQ:HROWHarrow Inc
02/21/20247:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HROWHarrow Inc
02/21/20247:29PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HROWHarrow Inc
02/15/20244:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:HROWHarrow Inc
02/15/20244:01PMBusiness WireHarrow Licenses Canadian Rights to Apotex for Five Branded Ophthalmic Pharmaceutical ProductsNASDAQ:HROWHarrow Inc
02/09/20244:05PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:HROWHarrow Inc
02/08/20247:30AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HROWHarrow Inc
01/29/20244:30PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:HROWHarrow Inc
01/29/20243:26PMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:HROWHarrow Inc
01/29/20247:00AMBusiness WireHarrow Announces New Appointments to its Board of DirectorsNASDAQ:HROWHarrow Inc
01/11/20247:00AMBusiness WireHarrow Announces Availability of VEVYE® (Cyclosporine Ophthalmic Solution) 0.1%, the First and Only Cyclosporine-Based Product Indicated for Treating Both Signs and Symptoms of Dry Eye DiseaseNASDAQ:HROWHarrow Inc
01/09/202410:16AMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:HROWHarrow Inc
01/03/20248:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:HROWHarrow Inc
01/03/20247:15AMBusiness WireMelt Pharmaceuticals Provides Corporate UpdateNASDAQ:HROWHarrow Inc
01/03/20247:00AMBusiness WireHarrow Partners with Leading Healthcare Market Access Technology PlatformsNASDAQ:HROWHarrow Inc
11/29/20237:00AMBusiness WireHarrow Completes Transfer of the TRIESENCE® New Drug ApplicationNASDAQ:HROWHarrow Inc
11/20/20237:00AMBusiness WireHarrow to Present at Two Investor Conferences in NovemberNASDAQ:HROWHarrow Inc
11/16/20234:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HROWHarrow Inc
11/14/20237:02PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HROWHarrow Inc
11/13/20234:38PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:HROWHarrow Inc
11/13/20234:34PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:HROWHarrow Inc
11/13/20234:01PMBusiness WireHarrow Announces Third Quarter 2023 Financial ResultsNASDAQ:HROWHarrow Inc
11/03/20234:52PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:HROWHarrow Inc
 Showing the most relevant articles for your search:NASDAQ:HROW